Cancer Center Amsterdam

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma

Verkleij, C. P. M., Frerichs, K. A., Broekmans, M. E. C., Duetz, C., O'Neill, C. A., Bruins, W. S. C., Homan-Weert, P. M., Minnema, M. C., Levin, M-D., Broijl, A., Bos, G. M. J., Kersten, M. J., Klein, S. K., Shikhagaie, M. M., Casneuf, T., Abraham, Y., Smets, T., Vanhoof, G., Cortes-Selva, D., van Steenbergen, L., & 7 othersRamos, E., Verona, R. I., Krevvata, M., Sonneveld, P., Zweegman, S., Mutis, T. & van de Donk, N. W. C. J., 2 May 2023, In: HemaSphere. 7, 5, p. E881

Research output: Contribution to journal › Article › Academic › peer-review

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma

van Zogchel, L. M. J., van Wezel, E. M., van Wijk, J., Stutterheim, J., Bruins, W. S. C., Zappeij-Kannegieter, L., Slager, T. J. E., Schumacher-Kuckelkorn, R., Verly, I. R. N., van der Schoot, C. E. & Tytgat, G. A. M., 2019, In: JCO Precision Oncology. 3, p. 291-306 16 p.

Research output: Contribution to journal › Article › Academic › peer-review